I suppose the question really is who has the most influence with the FDA? Pfizer/Sarepta most likely wanting to slow ANP's progress because they want GT to win the race and/or want to buy ANP out with a low ball offer, or will the PPMD succeed in helping us fast track to the next trial? I notice that the PPMD annual (virtual) congress is in 4 weeks time. Both Pfizer and Sarepta are platinum sponsors.. Billions of dollars at stake in one hand and the lives of these poor boys in the other... let's hope compassion prevails and it doesn't become political. The next few days will tell all...
Where others have failed will Atl1102 succeed ?, page-42
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $69.41M | |||
| Open | High | Low | Value | Volume |
| 7.7¢ | 8.0¢ | 7.7¢ | $134.7K | 1.732M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99278 | 7.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 122500 | 1 |
View Market Depth
| Last trade - 16.10pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.7¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 7.9¢ | 8.0¢ | 7.7¢ | 70281 | ||
| Last updated 15.51pm 07/05/2024 ? | |||||
| PER (ASX) Chart |